May 15, 2026 04:01PM
May 11, 2026 04:30PM
Apr 24, 2026 09:25AM
Apr 24, 2026 09:00AM
Apr 20, 2026 08:00AM
Apr 2, 2026 08:45AM
Mar 30, 2026 04:05PM Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 27, 2026 07:23PM
Mar 27, 2026 07:23PM
Mar 27, 2026 07:00AM
Mar 23, 2026 04:30PM
Nov 13, 2025 08:30AM
Nov 6, 2025 08:00AM
Oct 3, 2025 09:00AM Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Aug 19, 2025 08:00AM
Aug 13, 2025 06:08PM
Aug 13, 2025 04:30PM
Jul 25, 2025 09:00AM
May 15, 2025 05:03PM
May 15, 2025 08:45AM
May 8, 2025 08:30AM Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET
Mar 27, 2025 04:01PM
Mar 20, 2025 08:00AM
Nov 7, 2024 04:49PM
Nov 7, 2024 04:05PM
Oct 31, 2024 08:00AM
Aug 8, 2024 04:01PM
Aug 5, 2024 08:00AM Lantern Pharma Announces Positive Clinical Update from Ongoing Phase 2 HARMONIC™ Clinical Trial for Never Smokers with Advanced NSCLC, Including an 86% Clinical Benefit Rate in the Initial Patient C
Aug 1, 2024 08:00AM
May 9, 2024 04:45PM
May 9, 2024 04:02PM
May 2, 2024 07:30AM
Mar 18, 2024 04:10PM
Mar 18, 2024 04:02PM
Mar 11, 2024 07:30AM Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
Nov 8, 2023 04:05PM
Nov 8, 2023 04:01PM
Nov 1, 2023 08:00AM
Aug 9, 2023 04:55PM
Aug 9, 2023 04:01PM
Aug 2, 2023 12:45PM
Aug 2, 2023 08:00AM Lantern Pharma to Report Second Quarter 2023 Operating & Financial Results on August 9, 2023 at 4:30 p.m. ET
May 9, 2023 04:21PM
May 9, 2023 04:01PM
May 2, 2023 04:01PM
Mar 20, 2023 04:03PM
Mar 20, 2023 04:01PM
Mar 13, 2023 08:00AM
Nov 7, 2022 04:01PM Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights
Oct 31, 2022 08:00AM

1,198,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All